• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

The analysis of mechanism of Theiler's virus-induced damyelination in L* protein transgenic mice

Research Project

Project/Area Number 13670673
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionKANAZAWA MEDICAL UNIVERSITY

Principal Investigator

ASAKURA Kunihiko  Kanazawa Medical University, Department of Microbiology, Associate Professor, 医学部, 助教授 (50333159)

Co-Investigator(Kenkyū-buntansha) HIMEDA Toshiki  Kanazawa Medical University, Department of Microbiology, Research Associate, 医学部, 助手 (80340008)
OHARA Yoshiro  Kanazawa Medical University, Department of Microbiology, Professor, 医学部, 教授 (50203914)
Project Period (FY) 2001 – 2002
KeywordsMultiple sclerosis / Theiler's virus / Demyelination / L* protein / Transgenic mouse / Lentivirus
Research Abstract

Theiler's murine encephalomyelitis virus (TMEV) is classified into two subgroups based on the difference in biological activities. DA strain causes chronic inflammatory demyelination in the spinal cord in susceptible strains of mice. This serves as an experimental model of multiple sclerosis, human demyelinating disease in the central nervous system (CNS). The precise mechanism of persistent infection and demyelination by DA strain is yet to be elucidated. DA strain translates 17 kDa protein, designated L*, which is out of frame with the virus. To elucidate the mechanism of persistent infection of TMEV and demyelination, in this study we tried to generate transgenic mice expressing L* protein under different promoters. We generated the constructs which have L* protein cDNA under MHC class I or iNOS or chicken β-actin promoter. These constructs were injected into FVB/NJ mouse embryo. The expression of L* was not verified in vivo although robust expression of L* was observed in vitro. Therefore, we generated the immortalized macrophage cell line J774 expressing L* protein by using lentivirus vector. Macrophage is considered as the reservoir of TMEV in chronic phase of the disease. When J774 was infected with DAL*-1, which fails to synthesize L* and has attenuated demyelinating activity in the CNS, the virus failed to grow. In contrast, DAL*-1 virus was able to grow in J774 expressing L* indicating that L* is important to grow in macrophage. In addition, the mutant virus expressing epitope-tagged L* was generated and the L* expression in the CNS in acute phase of the disease was analyzed. In acute phase, L* was expressed in the CNS in both susceptible and resistant strains of mice suggesting that L* expression itself is not a determining factor of chronic infection and demyelination.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Obuchi M: "Association of L^* protein of Theiler's murine encephalomyelitis virus with microtubules in infected cells"Virology. 289・1. 95-102 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Bieber AJ: "Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice"Glia. 37・3. 241-249 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohara Y: "Distinct cell death mechanisms by Theiler's murine encephalomyelitis virus (TMEV) infection in microglia and macrophage"Neuroscience Letters. 327・1. 41-44 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Asakura K: "Epitope-tagged L^* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection"Journal of Virology. 76・24. 13049-13054 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohara Y: "Effects of L^* protein of Theiler's murine encephalomyelitis virus (TMEV) on its biological activities"Journal of Kanazawa Medical University. 27・2. 108-111 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 朝倉 邦彦: "免疫性神経疾患のγグロブリン療法"最新医学. 57・1. 123-127 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 朝倉 邦彦: "多発性硬化症の脱髄モデルと免疫グロブリン療法"神経免疫学. 10・2. 123-127 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 朝倉 邦彦(分担): "21世紀の神経免疫学-展望"医歯薬出版. 207 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Obuchi M et al.: "Association of L* protein of Theiler's murine encephalomyelitis virus with microtubules in infected cells"Virology. 289. 95-102 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Bieber AJ et al.: "Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice"Glia. 37. 241-249 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ohara Y et al.: "Distinct cell death mechanisms by Theiler's murine encephalomyelitis virus (TMEV) infection in microglia and macrophage"Neuroscience Letters. 327. 41-44 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Asakura K et al.: "Epitope-tagged L* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection"J. Virology. 76. 13049-13054 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ohara Y et al.: "Effects of L* protein of Theiler's murine encephalomyelitis virus (TMEV) on its biological activities"J. Kanazawa Medical University. 27. 108-111 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi